ProCE Banner Activity

Heart Failure Transitions of Care Considerations

Clinical Thought

Javed Butler, MD, MPH, MBA discusses the importance of optimizing guideline-recommended treatment in patients with heart failure at transitions of care.

Released: March 27, 2023



Javed Butler

Javed Butler, MD, MPH, MBA

Baylor Scott and White Research Institute
Dallas, Texas
Distinguished Professor of Medicine
Department of Medicine
University of Mississippi Medical Center
Jackson, Mississippi

Provided by

ProCE Banner
ProCE Banner


This educational activity is supported by education grants from

Boehringer Ingelheim Pharmaceuticals, Inc.

Novartis Pharmaceuticals Corporation

Faculty Disclosure

Javed Butler, MD, MPH, MBA: consultant: Abbott, Adrenomed, Amgen, Array, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, CVRx, G3 Pharmaceutical, Impulse Dynamics, Innolife, Janssen, LivaNova, Luitpold, Medtronic, Merck, Novartis, Novo Nordisk, Roche, Vifor; speaker: AstraZeneca, Boehringer Ingelheim, Impulse Dynamics, Merck, Novartis, Vifor.